XLV News 61.23 06/27/2014 05:46:57 Healthcare Select Sector SPDR

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Healthcare Select Sector SPDR (XLV) 61.23 $XLV

XPH Crushing the Pharma ETFs Competition - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Jun 20, 1:00PM CDT
This ETF is considered a solid pick given its strong fundamentals and the growing pharma space.

Medical Device ETF in Focus as Medtronic Buys Covidien - ETF News And Commentary
Sweta Killa - ZACKS - Mon Jun 16, 1:00PM CDT
Medtronic agreed to buy Irish rival Covidien for $42.9 billion. Investors looking to tap this opportunity should consider the medical device ETF.

Powerhouse ETFs: Transports and Technology Are the Best Performers
at The Street - Thu Jun 12, 10:58AM CDT
I continue to track 11 Exchange Traded Funds as a conservative way to invest in specific sectors of the stock market in an environment where stock-picking remains difficult.

Medtronic Earnings Drags Medical Device ETF Lower - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu May 22, 11:00AM CDT
The medical device ETF is looking weak following lackluster results from Medtronic (MDT).

Powerhouse ETFs: Energy, Consumer Staples and Utilities Outperform
at The Street - Mon May 12, 12:03PM CDT
There are 11 Exchange Traded Funds that provide a conservative way to invest in specific sectors without the risk of stock picking.

Health Care Select Sector SPDR Fund Experiences Big Outflow
ETFChannel.com - Fri May 09, 9:49AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Health Care Select Sector SPDR Fund where we have detected an approximate $264.3 million dollar outflow -- that's a...

How Will Pfizer Treat These Healthcare ETFs? - ETF News And Commentary
Sweta Killa - ZACKS - Tue May 06, 1:00PM CDT
Will Pfizer's earnings and its failed bid for AstraZeneca drag down these healthcare ETFs?

Merck (MRK) Earnings Beat Puts Healthcare ETFs in Focus - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu May 01, 12:34PM CDT
These health care ETFs are in focus thanks to a solid earnings report from Merck (MRK).

Earnings from Gilead and Amgen Put These ETFs in Focus - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 7:00AM CDT
Solid results from Gilead, but poor results from Amgen, look to have a big impact on these health care ETFs.

Pharma M&A Frenzy Pushing These ETFs Higher - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Wed Apr 23, 1:00PM CDT
The ongoing flurry of M&A talks in the pharma industry is sending the drug stocks and the related ETFs higher.

Utilities, Health Care Leading ETF Sectors
at The Street - Wed Apr 02, 9:15AM CDT
Here are some investments to get exposure to broad sectors in the economy.

Health-Care Stocks: Growing Like Gangbusters
Selena Maranjian, The Motley Fool - Motley Fool - Sat Mar 15, 8:30AM CDT
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some health-care stocks to your portfolio but don't have the time or expertise to hand-pick a few, the Health Care Select Sector SPDR...

ETF Sector Rotation: Industrials Out, Healthcare In - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 11:00AM CDT
Which ETFs have been seeing a surge in assets lately?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 54

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 250

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
AR Cards in Casino Gaming: A High-Stakes Revolution

Updated Category News Views 106

A New Breed of Casino Experience Walk into a casino today, and you might just enter a whole new reality. No, this isn’t a cheesy magician’s trick or a glitzy PR stunt—this is the real deal brought to you by augmented reality (AR) trading cards. Imagine the slots you love wrapped in a sci-fi movie where characters leap out, tap you on the shoulder, and call you by...

Continue Reading
LA Auto Show 2026: Thrills, Games, and Cars Galore

Updated Category News Views 82

A Family Day Like No Other at the LA Auto Show Kicking into gear this November, the 2026 Los Angeles Auto Show puts the pedal to the metal for families seeking a full day of fun without breaking the bank. We're talking about 10 solid days where auto-mania meshes with interactive experiences, all nestled in the Los Angeles Convention Center. Whether you're a gearhead or a...

Continue Reading
Texxon Faces Revenue Slide Amid Strategic Shifts

Updated Category News Views 176

Texxon's Strategic Transitions and Financial Headaches Texxon Holding Limited (NASDAQ:NPT) just laid their cards on the table, unveiling a mixed bag in their fiscal year 2026 results. As the world's chemical and plastics scene faces winds of change, Texxon buckled down and tried to steer the ship clear from the rocks. It's a balancing act juggling market headwinds, a new...

Continue Reading
PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 106

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Shareholder Alert: Investigation Looms Over GDYN

Updated Category News Views 103

Grid Dynamics Under Legal Scrutiny There’s nothing quite like waking up to find your pick embroiled in an investigation. Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) is on the radar, with law firm Levi & Korsinsky diving headfirst into potential infractions of fiduciary duties by some of the company’s top brass. The Lowdown on the Investigation This whole circus was...

Continue Reading
Triple Crossing Tests a Tough Inland Marine Market

Updated Category News Views 0

Inland marine is where tidy insurance appetites go to get bent out of shape. A contractor’s rented machine, cargo moving between points, a half-finished building, or equipment that is neither parked forever nor easy to classify can turn a standard quote into a week of broker phone calls. Triple Crossing Specialty is stepping directly into that mess, launching a new...

Continue Reading
Operation Healing Forces Partners with Wounded Warrior

Updated Category News Views 80

Joining Forces for Special Operations Families When it comes to the heavy lifting of supporting Special Operations Forces (SOF) families, two powerhouses—Operation Healing Forces (OHF) and Wounded Warrior Project (WWP)—are doubling down. They’re not just tossing around good intentions. Oh no, they’re pulling out the stops with a solid partnership focused on...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 359

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading

Top 5 Most Recently Viewed Articles

Marjorie Taylor Greene's Diverse Portfolio Emphasizes Growth

Updated Category News Views 243

Marjorie Taylor Greene's Investment Choices Marjorie Taylor Greene, a well-known congressional representative, is making headlines lately with her recent stock investments. Reports indicate that her investment decisions reflect a strong interest in diverse sectors, including technology, healthcare, and logistics. This varied approach highlights her strategic thinking as...

Continue Reading
RBB Bancorp's Incredible Third Quarter Gains and Dividend

Updated Category News Views 178

RBB Bancorp: A Review of Stellar Financial Performance RBB Bancorp, alongside its subsidiaries, has recently announced impressive financial results for the quarter ended September 30, 2025. In an era where financial stability is paramount, RBB Bancorp (NASDAQ:RBB) emerged with promising metrics indicating solid progress. Key Financial Highlights for Q3 2025 Net income...

Continue Reading
Hancock Whitney to Share Q3 2024 Results and Insights Soon

Updated Category News Views 69

Exciting News from Hancock Whitney Corporation Hancock Whitney Corporation (Nasdaq: HWC) is about to share its financial performance for the third quarter of 2024. This announcement will take place after the market closes, paving the way for an insightful conference call with both analysts and investors. Details on Financial Results and Conference Call The expected...

Continue Reading
GunsAmerica Reinforces Leading Role in Safe Online Firearm Sales

Updated Category News Views 229

GunsAmerica Reinforces Leading Role in Safe Online Firearm Sales GunsAmerica stands at the forefront of the online firearm marketplace, continually evolving to ensure the utmost safety and security for its users. The platform has earned a stellar reputation over its impressive 28-year history by prioritizing secure firearm transactions and implementing robust measures...

Continue Reading
Acrivon Therapeutics Pushes Ahead with ACR-2316 Trials

Updated Category News Views 70

Exciting Milestone in Oncology Trials Acrivon Therapeutics, Inc. has recently reached a significant milestone by dosing its first patient in the Phase 1 clinical trial of ACR-2316. This innovative WEE1/PKMYT1 inhibitor was developed using Acrivon’s advanced AP3 platform, which accelerates the discovery and design of effective cancer treatments. The progress marks a...

Continue Reading